Biotech Sell-Off: Momentum Eases on Profit Taking and Geopolitical Uncertainty…Update-2 Gene Therapy
Update-2...Biotech rally Friday and Gene Therapy stocks One clue to the stealth rally on Friday is this article in Barron's published Saturday (? hmmm) Why Big Pharma is Diving into Gene Therapy If you cannot access this article and are not a subscriber go plunk down $5 as there is other good...
Small Cap Biotechs Lead the Market in 2019 Up 20% YTD…GNMK, ONCE, XBI-Updates
Update: 1:40 EST 2/25... Gene Therapy stocks soar on Spark (ONCE) Deal: BLUE, CRSP, RARE; and XBI up 4.2%. Another big deal as GE sells healthcare business to Danher (DHR) for $21.4B; GE up 8.26%, DHR up 8.38%. ========== M&A Drives Mid and Small Cap Biotechs Stocks Higher The Small Cap...
J.P.Morgan Healthcare Conference: Picks and Trades… Updates GNMK
Update: GenMark (GNMK) Soars on Q4 and Full Year 2018 Results Revenues of $70.8M were 35% over 2017 Results Q4 Revenues were $19.4M an increase of 21% over prior year. ePlex Revenues for Q4 were 412.1M an increase of 110% over prior year. Loss per share was reduced from 26c per share to 21c per...
Biotech Stocks Hold After After Brief Sell-Off Last Week…Updates
Biotech Stocks Hold Despite Last Thursday's Sell-Off All in the Technicals For Now, Large Caps Look Steady Biotech ETFs lost momentum last week but held near term support near the 20 Day moving average. Now that most companies have reported we should not expect fundamentals to create...
Life Science ETFs Performance 2018-2019: FBT is the Leader…Updates 2/7
Update 2/7/19 Mid-Day Trading : Risk Off Day The market is trending down with all major indices in the red and the XBI $81.96 down 2.75%. We sold our position in the XBI yesterday at $83+. Array (ARRY) continues to run up at $21.60. Hot stock MacroGenics (MGNX) cooled off down 9% to $23.29....